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Open access under the Elsa b s t r a c t
Iron deﬁciency and visceral leishmaniasis are serious problems of public health. The aim of this study was
to evaluate the effect of iron deﬁciency, induced by the iron chelator desferrioxamine, on the course of
the infection by Leishmania chagasi in BALB/c mice. Our data show that the iron chelator caused signiﬁ-
cant reduction in hemoglobin concentration of treated mice and reduction in parasite load in spleen and
liver. Signiﬁcant differences were not observed in the production of IFN-gamma and IL-4 among the
experimental groups. In conclusion, the data reported in this paper suggest that iron deﬁciency may favor
the host. If there is not enough iron available to the parasite, its multiplication may be reduced and infec-
tion attenuated.
 2010 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Currently, both iron deﬁciency and infection caused by Leish-
mania parasites are considered serious problems of public
health which affect millions of people. Visceral leishmaniasis
(VL) has an annual incidence of 500,000 new cases (WHO,
2005), and recently, an increase in the number of cases has
been observed in many areas where there is a high prevalence
of iron deﬁciency.
Iron deﬁciency, according to the World Health Organization
(WHO), is the most prevalent nutritional disorder in the world af-
fects 1.62 billion people, (24.8% of the world population) (WHO,
2008) and affects mainly children under four years old, breast-
feeding and pregnant women and women of fertile age. In relation
to the genus Leishmania (Protozoa: Kinetoplastida), only a few
studies have evaluated the effect of iron deﬁciency on the infectionCiências Biológicas, Rodovia
utaí, GO, Brazil.
hermebioufop@yahoo.com.br
evier OA license.(Huynh et al., 2006; Huynh and Andrews, 2008; Das et al., 2009;
Carvalho et al., 2009 and Jacques et al., 2010). These authors have
demonstrated the importance of elemental iron for the replication
of pathogens in the host.
However, very little is known about the mechanisms involved
in the relationship between infection by L. chagasi and iron deﬁ-
ciency. As discussed by Malafaia (2008a), studies concerning iron
and infection have presented results which are frequently contra-
dictory, some showing that iron shortage increases susceptibility
to infectious processes whereas others show that iron excess is
much more harmful to the human host and that the iron shortage
could even play a protective role in certain infections. In the case of
infection by Leishmania, the capture of iron ions required for anti-
oxidizing functions and other metabolic reactions seems to be cru-
cial for their survival and multiplication (Marquis and Gros, 2007;
Huynh and Andrews, 2008; Malafaia, 2008b; Das et al., 2009).
Thus, the present work aimed to evaluate the effect of iron deﬁ-
ciency induced by the iron chelator desferrioxamine on L. chagasi
infection in BALB/c mice. Since few works have dealt with the
existing association between iron deﬁciency and VL caused specif-
ically by L. chagasi, this study may help to elucidate the complex
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course of VL.
2. Materials and methods
2.1. Animals, division of groups and experimental design
Female BALB/c mice (3–5 weeks old) were used and were ran-
domly divided into three experimental groups: uninfected and
not treated with desferrioxamine (DFO) (UNT) group, infected with
L. chagasi, but not treated (INT) group and infected and treated (IT)
group. The data presented in this study are from two experiments
performed independently (n = 8 mice/per group/per experiment).
Initially, all animals of the treated groups received an intraperi-
toneal (ip) injection of 10 mg of DFO (Desferal, Novartis, Basel,
Switzerland) in 100 lL of PBS (3 doses per week). The treatment
protocol was based on Arantes et al. (2007), regarding the route
of inoculation and concentration of the drug administered in each
animal (double the concentration used by Arantes et al. (2007) was
used in this study). The animals of the groups not treated with DFO
received the same amount of PBS over the same period.
After two weeks of treatment, animals in the infection groups
were infected with L. chagasi promastigotes, given intravenously
by lateral tail vein. In order to do this, promastigote forms of
L. chagasi strain (MHOM/BR/1974/M2682) were used. L. chagasi
was cultured at 26 C in Grace’s Insect Medium (Gibco BRL, Grand
Island, NY, USA) supplemented with 10% heat-inactivated fetal
calf serum (FCS; Cripion, Andradina, SP, Brazil), 2 mM-glutamine
(Gibco BRL) and 100 U/mL penicillin G potassium (USB Corporation,
Cleveland, OH, USA), pH 6.5 at 26 C. Infectivity was maintained
by serial passage in BALB/c mice. For the inoculation, promastig-
otes of L. chagasi were harvested from late-log-phase cultures by
centrifugation and washed three times in PBS. For the experimen-
tal infection, 1  107 promastigotes were suspended in 200 lL
RPMI, pH 7.2.
Two, four and six weeks after the infection with L. chagasi, the
infected mice were sacriﬁced and spleen and liver parasite loads
were determined. In this case, the parasite load was determined
by quantitative limiting dilution culture as described by Titus
et al. (1985) and modiﬁed by Marques-da-Silva et al. (2005), with
some modiﬁcations. Fragments of spleen and liver were obtained
and weighed separately for parasite quantiﬁcation. In addition
we decided to assess some immunological parameters including
production of cytokines IFN-gamma and IL-4, and the production
of NO by splenocytes. Single-cell suspensions of spleen were
obtained by tissue grinder homogenization and processed as
described previously (Marques-da-Silva et al., 2005) and the
production of IFN-gamma and IL-4 was determined in these super-
natants by ELISA (Afonso and Scott, 1993). The production of nitric
oxide (NO) was determined by the Greiss method (Green et al.,
1982). To prepare the L. chagasi antigen, parasites were disrupted
by three rounds of freezing and thawing (freeze–thawed antigen),
protein content was estimated by the Lowry method (Lowry et al.,
1951) and the preparation was frozen at 20 oC until use.
2.2. Levels of hemoglobin and physical parameters
To determine if the treatment with DFO was capable of reducing
the blood levels of hemoglobin (Hb) (which indicates a reduction in
the levels of iron), its concentration was determined in blood sam-
ples, collected from the ocular plexus, using a commercial assay
procedure (Labtest Kit catalogue No. 43). Evaluations were per-
formed in the second, fourth and sixth week after infection, on
the day of sacriﬁce.
To evaluate the effect of infection by L. chagasi and of DFO on
physical parameters, we measured the body weight and liver andspleen mass of the mice. The assessment of body weight was per-
formed weekly until the sacriﬁce of animals. The evaluations of or-
gan weight were performed on the day of animals’ sacriﬁce (2, 4
and 6 weeks after infection).
2.3. Statistical analyses and ethics issues
All data were analyzed by Kolmogorov–Smirnov normality test.
Data with a normal distribution were analyzed by Student’s t test
(data of body weight, organ weight and blood hemoglobin levels).
Data whose distributions were not considered normal were sub-
mitted to non-parametric Mann–Whitney’s test (data of parasite
load, cytokines and NO). Differences with a p value <0.05 were con-
sidered statistically signiﬁcant.
All animal procedures were approved by the Committee on
Ethics in Research of the Universidade Federal de Ouro Preto-MG,
Brazil, and followed the guidelines for the use and care of animals
for research published by the Canadian Council on Animal Care
(1980, 1984).
3. Results
3.1. Effect of treatment with DFO on total body weight and liver and
spleen mass
No difference in the total body weight between the experimen-
tal groups was observed (data not shown). In addition, no signiﬁ-
cant difference between the liver mass of the INT and IT groups
measured in the second, fourth and sixth weeks after infection
were observed. A signiﬁcant difference was observed between
UNT and INT groups and UNT and IT groups only in the sixth week
of evaluation (Fig. 1A).
There was no difference in spleen mass between the INT and IT
groups in the second, fourth and sixth weeks after infection. How-
ever, a signiﬁcant difference was observed between UNT and INT
groups and UNT and IT groups also only in sixth week of evaluation
(Fig. 1B).
3.2. Levels of hemoglobin
We did not observe signiﬁcant differences in hemoglobin be-
tween UNT and INT groups measured in the second, fourth and
sixth experimental weeks. However, signiﬁcant differences be-
tween INT and IT groups and UNT and IT groups were observed 4
and 6 weeks after infection (Fig. 2).
3.3. Parasite load in spleen and liver
In order to study the inﬂuence of iron deﬁciency on L. chagasi
infection in BALB/c mice, this study evaluated the parasite load
in spleen and liver. Our data show that the IT group had a signiﬁ-
cantly smaller splenic parasitic load compared to INT group
6 weeks after infection (Fig. 3A). Regarding hepatic parasitic load,
a signiﬁcant difference in number of parasites between the INT
and IT groups was observed when the evaluations were carried
out after 4 and 6 weeks of infection (Fig. 3B).
3.4. Determination of production of cytokine and NO
After mice were killed, spleen cells were harvested and
incubated in the presence or absence of freeze–thawed L. chagasi
antigen (50 lg/mL), in order to determine the cytokine levels
(IFN-gamma and IL-4) in culture supernatants. It was observed that
the treatment with DFO did not inﬂuence the production of
IFN-gamma and IL-4. Although the Leishmania antigen was able
Fig. 1. Liver (A) and spleen (B) mass of mice. The bars represent the mean-
s + standard deviation of data obtained in the sixth experimental week of two
independent experiments (n = 8/for group in each experiment). Statistical differ-
ences were determined by Student’s t test. Statistical differences between UNT and
INT groups and UNT and IT groups are represented by  and #, respectively
(p < 0.05). Animals were randomly divided into three experimental groups:
uninfected and not treated with desferrioxamine (DFO) (UNT) group, infected with
L. chagasi, but not treated (INT) group and infected and treated (IT) group.
Fig. 2. Levels of hemoglobin in mice in control and treated groups. Hemoglobin
concentration was determined, immediately after collection, in blood samples via
ocular plexus. The bars represent the means + standard deviation of data obtained
in the sixth experimental week of two independent experiments (n = 8/for group in
each experiment. Statistical differences were determined by Student’s t test.
Statistical differences between UNT and INT groups and UNT and IT groups are
represented by  and #, respectively (p < 0.05). Animals were randomly divided into
three experimental groups: uninfected and not treated with desferrioxamine (DFO)
(UNT) group, infected with L. chagasi, but not treated (INT) group and infected and
treated (IT) group.
Fig. 3. Splenic (A) and hepatic (B) parasitic load of mice. Two, four and six weeks
after inoculation of parasites, mice were sacriﬁced and their spleen and liver were
harvested for parasite quantiﬁcation by limiting-dilution quantitative culture. The
bars represent the means + standard deviation of data obtained in the second,
fourth and sixth experimental weeks of two independent experiments (eight
animals for group were sacriﬁced in each period of the evaluation). Statistical
differences were determined by non-parametric Mann–Whitney’s test. Statistical
differences between groups are represented by one asterisk (p < 344 0.05). Animals
were randomly divided into three experimental groups: uninfected and not treated
with desferrioxamine (DFO) (UNT) group, infected with L. chagasi, but not treated
(INT) group and infected and treated (IT) group.
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ference was observed between the INT and IT groups, when the
evaluations were performed in the second, fourth and sixth weeks
after infection (Fig. 4A). Furthermore, no difference in the produc-
tion of IL-4 between INT and IT groups (Fig. 4B) was observed. No
signiﬁcant levels of NO were detected in the supernatants by the
method used (data not shown).4. Discussion
Iron is the most studied and best described micronutrients in
the literature, and plays important roles in human metabolism,
such as transport and storage of oxygen, energy release reactions
in the electron transport chain, conversion of ribose into deoxyri-
bose, and is a co-factor for some enzymatic reactions and other
essential metabolic processes (Cook et al., 1992). The greatest
amount of iron is found in hemoglobin; the remainder being dis-
tributed in other proteins, enzymes and in iron deposits (ferritin
and hemosiderin) (Yip and Dallman, 1997). As discussed by Marquis
and Gros (2007), Malafaia (2008b) and Das et al. (2009), consid-
ering infections, ﬁndings available in literature show that either
iron deﬁciency may favor the proliferation of parasites, once such
Fig. 4. Production of IFN-gamma (A) and IL- 4 (B) by spleen cells of mice studied.
The bars represent the means + standard deviation of data obtained in the second,
fourth and sixth experimental weeks of two independent experiments (eight
animals for group were sacriﬁced in each period of the evaluation). Statistical
differences were determined by non-parametric Mann–Whitney’s test. Statistical
differences between non-stimulated cultures and stimulated cultures are repre-
sented by one asterisk (p < 0.05). Animals were randomly divided into three
experimental groups: uninfected and not treated with desferrioxamine (DFO) (UNT)
group, infected with L. chagasi, but not treated (INT) group and infected and treated
(IT) group.
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that iron deﬁciency may favor the control of infection, as it limits
the amount of iron available to the parasite. There have been no
studies of infection caused by L. chagasi.
Treatment with DFO did not have any inﬂuence on the physical
parameters evaluated (total body weight and liver and spleen
mass). However, an increase in liver and spleen mass was observed
in mice of the infected groups (INT and/or IT) if compared to UNT
group only in the evaluation at the sixth week of infection (Fig. 1).
These data suggest a developing of hepatosplenomegaly in mice, a
typical sign of VL. However, this was not observed at the second
and fourth weeks after infection, which is not surprising as it is
progressive process.
Our data indicate that treatment with DFO was able to reduce
hemoglobin blood levels in the fourth and sixth weeks after infec-
tion (Fig. 2). In experimental models and humans, three stages of
iron deﬁciency have been described. The initial stage, iron deple-
tion, occurs when stored iron in the bone marrow diminishes
due to an insufﬁcient supply of iron. Generally this stage is asymp-
tomatic, creates no overt effect on erythropoiesis, and escapes
detection by hemoglobin or hematocrit screening. Continued ironstore depletion leads to the second stage, iron deﬁciency, during
which storage levels become substantially reduced and hemoglo-
bin synthesis begins to be affected. The ﬁnal stage, iron deﬁciency
anemia, develops when iron stores are insufﬁcient to maintain
hemoglobin production (Cook, 1999; Wu et al., 2002). Thus, the re-
sults obtained in our study allow us to infer possible iron deﬁ-
ciency in the treated mice.
Our data show that the DFO was able to provoke a signiﬁcant
reduction of hepatic parasitic load when the evaluations were per-
formed 4 and 6 weeks after infection (Fig. 3B). This was especially
apparent in the fourth week after infection (when the reduction
was greater), which coincides with a peak of hepatic parasitism
in mice infected by L. chagasi (Marques-da-Silva et al., 2005). In
the spleen, the decrease in parasite load was observed at the sixth
week after infection (Fig. 3A), which also coincides with the peak of
parasitism (Marques-da-Silva et al., 2005).
Similar data were observed in the recent works of Arantes et al.
(2007) and Francisco et al. (2008), involving murine infection by
Trypanosoma cruzi (Y strain) and use of DFO. These studies are
important because they also evaluated another representative of
the Trypanosomatidae family. In the ﬁrst case, the authors ob-
served a reduction in the parasite levels and a longer patent period
in the infected group treated with DFO. Francisco et al. (2008),
evaluated the effect of the treatment in Swiss mice infected with
Y strain of T. cruzi with the drug benznidazol (BZ) associated with
DFO. The results of this study showed that the treatment with DFO,
associated with BZ, was able to enhance BZ efﬁcacy and, therefore,
that modiﬁcation in iron stores increases BZ efﬁcacy.
The reduction of splenic and hepatic parasite burden observed
could be related to the effects of DFO on the production of IFN-
gamma and NO (cytokine and substance, respectively, directly in-
volved in the control of infection by L. chagasi in BALB/c mice).
However, the results in the present study do not support this, since
no signiﬁcant differences were observed between the production
of IFN-gamma (Fig. 4A) and the production of NO by the spleno-
cytes of treated mice. In addition, no changes were observed in
IL-4 (Th2 proﬁle) production in the animals of the treated group
(Fig. 4B).
Thus, the results presented in this paper provide clues that iron
deﬁciency may contribute to control the murine infection with
L. chagasi and that, therefore, may be related to lower parasite
levels. However, there must be a critical point at which iron deple-
tion is not so great as to negatively interfere in the functioning of
the immune system while at the same time is enough to damage
the parasite.
These results are a ﬁrst step in understanding the relationship
between iron deﬁciency and VL. It is clear that further work will
be needed to elucidate other aspects such as the mechanism by
which iron deﬁciency reduces the parasite load in mice infected
with L. chagasi. Further investigation is also needed into of the
inﬂuence of iron deﬁciency on the immune response and the pro-
duction of other cytokines, such as IL-10 and TNF, which may be
altered in iron deﬁciency conditions and VL?References
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